KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Halozyme Therapeutics (HALO) over the last 17 years, with Q4 2025 value amounting to $435.7 million.

  • Halozyme Therapeutics' Other Operating Expenses rose 62844.34% to $435.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $639.0 million, marking a year-over-year increase of 17727.43%. This contributed to the annual value of $639.0 million for FY2025, which is 17727.43% up from last year.
  • Per Halozyme Therapeutics' latest filing, its Other Operating Expenses stood at $435.7 million for Q4 2025, which was up 62844.34% from $73.0 million recorded in Q3 2025.
  • Halozyme Therapeutics' Other Operating Expenses' 5-year high stood at $435.7 million during Q4 2025, with a 5-year trough of $15.9 million in Q1 2022.
  • Its 5-year average for Other Operating Expenses is $70.0 million, with a median of $58.6 million in 2024.
  • Per our database at Business Quant, Halozyme Therapeutics' Other Operating Expenses tumbled by 1783.27% in 2021 and then soared by 62844.34% in 2025.
  • Quarter analysis of 5 years shows Halozyme Therapeutics' Other Operating Expenses stood at $21.6 million in 2021, then soared by 116.2% to $46.7 million in 2022, then skyrocketed by 50.11% to $70.1 million in 2023, then dropped by 14.62% to $59.8 million in 2024, then skyrocketed by 628.44% to $435.7 million in 2025.
  • Its last three reported values are $435.7 million in Q4 2025, $73.0 million for Q3 2025, and $64.1 million during Q2 2025.